Search Results - "Arnaud Bourdin"

Refine Results
  1. 1

    Oral Glucocorticoid–Sparing Effect of Benralizumab in Severe Asthma by Nair, Parameswaran, Wenzel, Sally, Rabe, Klaus F, Bourdin, Arnaud, Lugogo, Njira L, Kuna, Piotr, Barker, Peter, Sproule, Stephanie, Ponnarambil, Sandhia, Goldman, Mitchell

    Published in The New England journal of medicine (22-06-2017)
    “…The use of benralizumab, a monoclonal antibody directed against the alpha subunit of the interleukin-5 receptor, allowed patients with asthma who were…”
    Get full text
    Journal Article
  2. 2

    Tezepelumab in Adults and Adolescents with Severe, Uncontrolled Asthma by Menzies-Gow, Andrew, Corren, Jonathan, Bourdin, Arnaud, Chupp, Geoffrey, Israel, Elliot, Wechsler, Michael E, Brightling, Christopher E, Griffiths, Janet M, Hellqvist, Åsa, Bowen, Karin, Kaur, Primal, Almqvist, Gun, Ponnarambil, Sandhia, Colice, Gene

    Published in The New England journal of medicine (13-05-2021)
    “…Tezepelumab is a monoclonal antibody that blocks thymic stromal lymphopoietin, an epithelial-cell–derived cytokine implicated in the pathogenesis of asthma…”
    Get full text
    Journal Article
  3. 3

    Short-course systemic corticosteroids in asthma: striking the balance between efficacy and safety by Price, David, Castro, Mario, Bourdin, Arnaud, Fucile, Sebastian, Altman, Pablo

    Published in European respiratory review (31-03-2020)
    “…Short courses of systemic corticosteroids (SCS), both oral and injectable, are very effective for the resolution of acute asthma symptoms, including…”
    Get full text
    Journal Article
  4. 4

    Systematic Literature Review of Systemic Corticosteroid Use for Asthma Management by Bleecker, Eugene R, Menzies-Gow, Andrew N, Price, David B, Bourdin, Arnaud, Sweet, Stephen, Martin, Amber L, Alacqua, Marianna, Tran, Trung N

    “…Systemic corticosteroid use to manage uncontrolled asthma and its associated healthcare burden may account for important health-related adverse effects. We…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Matching-adjusted indirect comparison of benralizumab versus interleukin-5 inhibitors for the treatment of severe asthma: a systematic review by Bourdin, Arnaud, Husereau, Don, Molinari, Nicolas, Golam, Sarowar, Siddiqui, Mohd Kashif, Lindner, Leandro, Xu, Xiao

    Published in The European respiratory journal (01-11-2018)
    “…Benralizumab is an interleukin-5 receptor α-directed cytolytic monoclonal antibody that directly depletes eosinophils. Its relative efficacy other…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9
  10. 10

    Natural history and mechanisms of COPD by Lange, Peter, Ahmed, Engi, Lahmar, Zakaria Mohamed, Martinez, Fernando J., Bourdin, Arnaud

    Published in Respirology (Carlton, Vic.) (01-04-2021)
    “…ABSTRACT The natural history of COPD is complex, and the disease is best understood as a syndrome resulting from numerous interacting factors throughout the…”
    Get full text
    Journal Article
  11. 11

    Bronchial epithelium as a target for innovative treatments in asthma by GRAS, Delphine, CHANEZ, Pascal, VACHIER, Isabelle, PETIT, Aurélie, BOURDIN, Arnaud

    Published in Pharmacology & therapeutics (Oxford) (01-12-2013)
    “…Increasing evidence of a critical role played by the bronchial epithelium in airway homeostasis is opening new therapeutic avenues. Its unique situation at the…”
    Get full text
    Journal Article
  12. 12

    Mortality: a neglected outcome in OCS-treated severe asthma by Bourdin, Arnaud, Molinari, Nicolas, Vachier, Isabelle, Pahus, Laurie, Suehs, Carey, Chanez, Pascal

    Published in The European respiratory journal (01-11-2017)
    “…Severe asthma, especially if associated with a T2 phenotype, often responds well to new emerging therapies, which have led to a reduction in the use of…”
    Get full text
    Journal Article
  13. 13
  14. 14
  15. 15

    From DREAM to REALITI‐A and beyond: Mepolizumab for the treatment of eosinophil‐driven diseases by Pavord, Ian D., Bel, Elisabeth H., Bourdin, Arnaud, Chan, Robert, Han, Joseph K., Keene, Oliver N., Liu, Mark C., Martin, Neil, Papi, Alberto, Roufosse, Florence, Steinfeld, Jonathan, Wechsler, Michael E., Yancey, Steven W.

    Published in Allergy (Copenhagen) (01-03-2022)
    “…Effective treatment of inflammatory diseases is often challenging owing to their heterogeneous pathophysiology. Understanding of the underlying disease…”
    Get full text
    Journal Article
  16. 16
  17. 17
  18. 18
  19. 19

    Mask side-effects in long-term CPAP-patients impact adherence and sleepiness: the InterfaceVent real-life study by Rotty, Marie-Caroline, Suehs, Carey M, Mallet, Jean-Pierre, Martinez, Christian, Borel, Jean-Christian, Rabec, Claudio, Bertelli, Fanny, Bourdin, Arnaud, Molinari, Nicolas, Jaffuel, Dany

    Published in Respiratory research (15-01-2021)
    “…For some patients, Continuous Positive Airway Pressure (CPAP) remains an uncomfortable therapy despite the constant development of technological innovations…”
    Get full text
    Journal Article
  20. 20

    Predictive factors for a one-year improvement in nontuberculous mycobacterial pulmonary disease: An 11-year retrospective and multicenter study by Cadelis, Gilbert, Ducrot, Rodolphe, Bourdin, Arnaud, Rastogi, Nalin

    Published in PLoS neglected tropical diseases (01-08-2017)
    “…Nontuberculous mycobacterial pulmonary disease (NTM-PD) has become an emerging infectious disease and is responsible for more deaths than tuberculosis in…”
    Get full text
    Journal Article